Authorized purpose: Non-invasive processing of adult ultrasound for cardiac measurements including LVEF, wall thickness, and IVC diameter, plus lung and cardiac image-quality feedback in patients with suspected disease.
Clinical role
Real-time acquisition-quality feedback and measurement support; the algorithm/API modules are intended as accessories integrated by a programmer into a legally marketed ultrasound imaging device, while clinicians remain responsible for interpretation and management.
Images and patients
Ultrasound · Heart and lungs
Key limitation
Keep in mind: The device is for adults and patient-management decisions must not rely solely on its analysis. Certified healthcare professionals must review the data and ensure scan quality and diagnostic appropriateness. The packet establishes module-specific validation, not a single performance result for every possible ultrasound use.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Non-invasive processing of adult ultrasound for cardiac measurements including LVEF, wall thickness, and IVC diameter, plus lung and cardiac image-quality feedback in patients with suspected disease.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart and lungs Input: Single- and multi-frame DICOM ultrasound images from scanners within the specified compatibility range, including apical four-chamber and parasternal long-axis cardiac views and lung scans.
Who uses it?Intended users: Qualified healthcare professionals trained to conduct echocardiography and lung ultrasound scans; certified healthcare professionals interpret the data and remain responsible for scan quality and diagnosis.
What does the software produce?Output: Lung A-line and B-line presence or count and per-frame or per-clip quality scores; cardiac LVEF, interventricular-septum and posterior-wall thickness from the PLAX view, IVC minimum diameter on inspiration, IVC maximum diameter on expiration, and cardiac quality scores.
What is its most important limitation?Key limitation: The device is for adults and patient-management decisions must not rely solely on its analysis. Certified healthcare professionals must review the data and ensure scan quality and diagnostic appropriateness. The packet establishes module-specific validation, not a single performance result for every possible ultrasound use.
Clinical takeaway. Clinical role: Non-invasive processing of adult ultrasound for cardiac measurements including LVEF, wall thickness, and IVC diameter, plus lung and cardiac image-quality feedback in patients with suspected disease.
Evidence takeaway. Evidence from the reviewed source record: FDA validation evaluated left-ventricular wall thickness and IVC measurements in 100 subjects each against the average of three experts: ICC 0.93 for IVSd (95% CI 0.89-0.96), 0.94 for PWd (0.89-0.97), 0.93 for IVC minimum diameter (0.90-0.95), and 0.94 for IVC maximum diameter (0.90-0.96). Quality AI used 184 patients, 226 clips, and 29,732 frames, with ICC 0.94 for frames (95% CI 0.94-0.95) and clips (0.92-0.95). In real-time testing, 396 scans were performed by 26 users, including 18 novices with two hours of training; 98.3% and 98.0% were conditional agreement proportions against expert quality ratings.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Non-invasive processing of adult ultrasound for cardiac measurements including LVEF, wall thickness, and IVC diameter, plus lung and cardiac image-quality feedback in patients with suspected disease.
Real-time acquisition-quality feedback and measurement support; the algorithm/API modules are intended as accessories integrated by a programmer into a legally marketed ultrasound imaging device, while clinicians remain responsible for interpretation and management.
Single- and multi-frame DICOM ultrasound images from scanners within the specified compatibility range, including apical four-chamber and parasternal long-axis cardiac views and lung scans.
Lung A-line and B-line presence or count and per-frame or per-clip quality scores; cardiac LVEF, interventricular-septum and posterior-wall thickness from the PLAX view, IVC minimum diameter on inspiration, IVC maximum diameter on expiration, and cardiac quality scores.
Qualified healthcare professionals trained to conduct echocardiography and lung ultrasound scans; certified healthcare professionals interpret the data and remain responsible for scan quality and diagnosis.
The device is for adults and patient-management decisions must not rely solely on its analysis. Certified healthcare professionals must review the data and ensure scan quality and diagnostic appropriateness. The packet establishes module-specific validation, not a single performance result for every possible ultrasound use.
FDA validation evaluated left-ventricular wall thickness and IVC measurements in 100 subjects each against the average of three experts: ICC 0.93 for IVSd (95% CI 0.89-0.96), 0.94 for PWd (0.89-0.97), 0.93 for IVC minimum diameter (0.90-0.95), and 0.94 for IVC maximum diameter (0.90-0.96). Quality AI used 184 patients, 226 clips, and 29,732 frames, with ICC 0.94 for frames (95% CI 0.94-0.95) and clips (0.92-0.95). In real-time testing, 396 scans were performed by 26 users, including 18 novices with two hours of training; 98.3% and 98.0% were conditional agreement proportions against expert quality ratings.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA validation evaluated left-ventricular wall thickness and IVC measurements in 100 subjects each against the average of three experts: ICC 0.93 for IVSd (95% CI 0.89-0.96), 0.94 for PWd (0.89-0.97), 0.93 for IVC minimum diameter (0.90-0.95), and 0.94 for IVC maximum diameter (0.90-0.96). Quality AI used 184 patients, 226 clips, and 29,732 frames, with ICC 0.94 for frames (95% CI 0.94-0.95) and clips (0.92-0.95). In real-time testing, 396 scans were performed by 26 users, including 18 novices with two hours of training; 98.3% and 98.0% were conditional agreement proportions against expert quality ratings.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
AI Platform 2.0 (AIP002) regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K240953
Samplen=184
IndependenceIndependence not established
K240953
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K240953. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Single- and multi-frame DICOM ultrasound images from scanners within the specified compatibility range, including apical four-chamber and parasternal long-axis cardiac views and lung scans.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Accepts DICOM data from ultrasound scanners in the specified range; the AI algorithm and API modules are intended to be integrated by another programmer into a legally marketed ultrasound imaging device. Exact local interfaces and versions are not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: Lung A-line and B-line presence or count and per-frame or per-clip quality scores; cardiac LVEF, interventricular-septum and posterior-wall thickness from the PLAX view, IVC minimum diameter on inspiration, IVC maximum diameter on expiration, and cardiac quality scores.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Lung A-line and B-line presence or count and per-frame or per-clip quality scores; cardiac LVEF, interventricular-septum and posterior-wall thickness from the PLAX view, IVC minimum diameter on inspiration, IVC maximum diameter on expiration, and cardiac quality scores.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Accepts DICOM data from ultrasound scanners in the specified range; the AI algorithm and API modules are intended to be integrated by another programmer into a legally marketed ultrasound imaging device. Exact local interfaces and versions are not established.
Exo's Security Trust Center describes a company-wide security program for its cloud and mobile applications: information security policies based on ISO/IEC 27001, software development lifecycle security practices covering the platform and all applications, ongoing penetration testing of cloud services and applications, continuous monitoring with incident response, and business continuity plans validated by third-party audits (SOC 2, HITRUST, ISO 27001).
Vendor-wide
Checked 2026-10-27
Vendor statements; no certificates or audit reports read. Exo's dated HITRUST/SOC 2 certification announcement is scoped to the Exo Works workflow product specifically. Applicant 'Exo Imaging' bridges to Exo (exo.inc). Exact-release scope is not established.
Exo's security trust center states ongoing penetration testing, continuous monitoring and incident response across its platform and applications, with business continuity validated by third-party audits.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names Exo generally and does not scope these practices to any specific product release; exact-release scope is not established. Audit reports were not read.
ACR AI Central provides an exact-submission model card for AI Platform 2.0 (AIP002); FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K240953 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.
Authorized purpose: Provides AI-assisted cardiac, lung and abdominal quality feedback and measurements; users remain responsible for scan quality and diagnosis and must not rely solely on the software.
Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.